American Psychiatric Association (1999) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington

Google Scholar 

Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59:102–112

Article  PubMed  Google Scholar 

Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation. Brain Res 888:287–296

Article  PubMed  CAS  Google Scholar 

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259

Article  PubMed  CAS  Google Scholar 

Braak H, Braak E, Yilmazer D, Vos RA de, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson’s and Alzheimer’s diseases. J Neural Transm 103:455–490

Article  PubMed  CAS  Google Scholar 

Braak H, Braak E, Yilmazer D, Vos RA de, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol 88:493–500

Article  PubMed  CAS  Google Scholar 

Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5

Google Scholar 

Braak H, Del Tredici K, Rüb U, Vos RA de, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

Article  PubMed  Google Scholar 

Braak H, Rüb U, Braak E (2000) Neuroanatomie des Morbus Parkinson. Veränderungen des neuronalen Zytoskeletts in nur wenigen für den Krankheitsprozess empfänglichen Nervenzelltypen führen zur progredienten Zerstörung umschriebener Bereiche des limbischen und des motorischen Systems. Nervenarzt 71:459–469

Google Scholar 

Braak H, Rüb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. doi:10.1007/s00702-002-0808-2 (published online March 5, 2003)

PubMed  Google Scholar 

Braak H, Rüb U, Sandmann-Keil D, Gai WP, Vos RA de, Jansen Steur EN, Arai K, Braak E (2000) Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 99:489–495

Article  PubMed  CAS  Google Scholar 

Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL 3rd (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57:39–46

Article  PubMed  CAS  Google Scholar 

Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain 122:1437–1448

Article  PubMed  Google Scholar 

Del Tredici K, Rüb U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426

PubMed  Google Scholar 

DeLucia MW, Cookson N, Dickson DW (2002) Synuclein-immunoreactive Lewy bodies are detected in the amygdala in less than 20% of Alzheimer’s disease (AD) cases. J Neuropathol Exp Neurol 61:454

Google Scholar 

Dickson DW (2001) α-Synuclein and the Lewy body disorders. Curr Opin Neurol 14:423–432

Article  PubMed  CAS  Google Scholar 

Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210

Article  PubMed  CAS  Google Scholar 

Eadie MJ (1963) The pathology of certain medullary nuclei in parkinsonism. Brain 86:781–795

Article  PubMed  CAS  Google Scholar 

Fearnley JM, Lees AJ (1994) Pathology of Parkinson disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545–554

Google Scholar 

Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental” state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

Article  PubMed  CAS  Google Scholar 

Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272

Article  PubMed  CAS  Google Scholar 

Gai WP, Blumbergs PC, Geffen LB, Blessing WW (1992) Age-related loss of dorsal vagal neurons in Parkinson’s disease. Neurology 42:2106–2111

PubMed  CAS  Google Scholar 

Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39

Article  PubMed  CAS  Google Scholar 

Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, Mukaetova-Ladinska E, Arendt T, Wischik CM (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease. Acta Neuropathol 95:154–158

Article  PubMed  CAS  Google Scholar 

Gibb WR, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease. Neuropathol Appl Neurobiol 15:27–44

Article  PubMed  CAS  Google Scholar 

Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brain stem neurons in Parkinson’s disease. Ann Neurol 27:373–385

Article  PubMed  CAS  Google Scholar 

Hamilton RL (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol 10:378–384

Article  PubMed  CAS  Google Scholar 

Hansen L, Salmon D, Galasko D, et al (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 40:1–8

PubMed  CAS  Google Scholar 

Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain 125:2431–2445

Article  PubMed  Google Scholar 

Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL (2000) Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol 57:1145–1150

Article  PubMed  CAS  Google Scholar 

Holstege G (1996) The somatic motor system. Prog Brain Res 107:9–26

Article  PubMed  CAS  Google Scholar 

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

Article  PubMed  CAS  Google Scholar 

Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870

Article  PubMed  Google Scholar 

Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) α-Synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921

PubMed  CAS  Google Scholar 

Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8:299–324

Article  PubMed  CAS  Google Scholar 

Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and α-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389–397

PubMed  CAS  Google Scholar 

Jellinger K (1991) Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153–197

Article  PubMed  CAS  Google Scholar 

Jellinger KA (2001) The pathology of Parkinson’s disease. Adv Neurol 86:55–72

PubMed  CAS  Google Scholar 

Jellinger KA, Bancher C (1998) Neuropathology of Alzheimer’s disease: a critical update. J Neural Transm Suppl 54:77–95

PubMed  CAS  Google Scholar 

Jellinger KA, Mizuno Y (2003) Parkinson disease. In: Dickson DW, et al (eds) Neurodegeneration and dementias. ISN Press, Los Angeles (in press)

Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 109:329–339

Article  PubMed  CAS  Google Scholar 

Jellinger KA, Seppi K, Wenning GK (2003) Neuropathologic changes in Parkinson disease with late onset of dementia. (Letter) Arch Neurol 60:452–454

Article  Google Scholar 

Kövari E, Gold G, Herrmenn FR, Canuto A, Hof PK, Bouras G, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson disease. Acta Neuropathol 106:83–88

PubMed  Google Scholar 

Lewy F (1913) Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 50:50–55

Google Scholar 

Lewy FH (1912) Paralysis agitans. Pathologische Anatomie. In: Lewandowsky M (ed) Handbuch der Neurologie. Springer, Berlin, pp 920–933

Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O’Connell B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370

Article  PubMed  CAS  Google Scholar 

Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to α-synuclein detect Lewy bodies in many Down’s syndrome brains with Alzheimer’s disease. Ann Neurol 45:353–357

Article  PubMed  CAS  Google Scholar 

Lowe J, Leigh PN (2002) Disorders of movement and system degenerations. In: Graham D, Lantos PL (eds) Greenfield’s neuropathology, 7th edn. Arnold, London, pp 325–430

Google Scholar 

Marui W, Iseki E, Nakai T, Miura S, Kato M, Ueda K, Kosaka K (2002) Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 195:153–159

Article  PubMed  Google Scholar 

Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) α-Synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathol 100:285–290

Article  PubMed  CAS  Google Scholar 

McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

PubMed  CAS  Google Scholar 

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486

PubMed  CAS  Google Scholar 

Nieuwenhuys R (1996) The greater limbic system, the emotional motor system and the brain. Prog Brain Res 107:551–580

Article  PubMed  CAS  Google Scholar 

Olszewski J, Baxter D (1982) Cytoarchitecture of the human brain stem, 2nd edn. Karger, Basel

Google Scholar 

Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62:363–367

PubMed  CAS  Google Scholar 

Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10:283–287

Article  PubMed  CAS  Google Scholar 

Perl DP, Purohit DP, Haroutunian V (1997) Clinicopathologic correlations of the Alzheimer disease staging system introduced by Braak and Braak. J Neuropathol Exp Neurol 56:577

Article  Google Scholar 

Perry RH, Irving D, Tomlinson BE (1990) Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J Neurol Sci 100:223–233

Article  PubMed  CAS  Google Scholar 

Schmidt ML, Martin JA, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders. Acta Neuropathol 91:475–481

Article  PubMed  CAS  Google Scholar 

Trembath Y, Rosenberg C, Ervin JF, Schmechel DE, Gaskell P, Pericak-Vance M, Vance J, Hulette CM (2003) Lewy body pathology is a frequent co-pathology in familial Alzheimer’s disease. Acta Neuropathol 105:484–488

PubMed  Google Scholar 

Wakabayashi K, Toyoshima Y, Awamori K, Anezaki T, Yoshimoto M, Tsuji S, Takahashi H (1999) Restricted occurrence of Lewy bodies in the dorsal vagal nucleus in a patient with late-onset parkinsonism. J Neurol Sci 165:188–191

Article  PubMed  CAS  Google Scholar 

Mikolaenko L, Kwan CH, O’Brien R, Petnikov O, Troncoso JC (2003) Abstr. 6th International Conference AD|PD 2003; Seville, Spain, 8–12 May 2003; p 133